Announce Date | 02/13/2025 |
EPS Normalized Actual | $1.4 (Beat by $0.03) |
EPS GAAP Actual | $1.4 (Beat by $0.03) |
Revenue Actual | $2.317B |
Revenue Surprise | Beat by $2317M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $1.66267 |
EPS GAAP Estimate | $1.66267 |
Revenue Estimate | $2.46551668B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 9.15 | 17.43 | 8.84576 | 9.52824 | 1 |
Dec 2028 | 8.37 | 19.05 | 8.25078 | 8.5459 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 1.28 | 1.28 | 2.317B | 4.49% | 2317M |
FQ3 2024 (Sep 2024) | 1.51 | 1.51 | 2.388B | 9.92% | 2388M |
FQ2 2024 (Jun 2024) | 1.37 | 1.37 | 2.361B | 7.67% | 2361M |
FQ1 2024 (Mar 2024) | 1.31 | 1.31 | 2.19B | 8.68% | 2190M |
FQ4 2023 (Dec 2023) | 1.14 | 1.14 | 2.213B | 7.82% | 2213M |
FQ3 2023 (Sep 2023) | 1.29 | 1.29 | 2.151B | 100% | 2151M |
FQ2 2023 (Jun 2023) | 1.45 | 1.45 | 2.18B | 5.87% | 2180M |
FQ1 2023 (Mar 2023) | 1.19 | 1.19 | 2B | 100% | 2000M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
1.66267
Consensus Revenue Estimates
2.46551668B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 1.92407 | -- | 1.86806 | 2.00971 | 3 |
FQ2 2027 (Jun 2027) | 1.82203 | -- | 1.76899 | 1.90313 | 5 |
FQ1 2027 (Mar 2027) | 1.61941 | -- | 1.57227 | 1.69149 | 3 |
FQ4 2026 (Oct 2026) | 1.7 | -- | 1.67982 | 1.71969 | 3 |
FQ3 2026 (Jul 2026) | 1.7 | -- | 1.67982 | 1.71969 | 5 |
FQ2 2026 (Jun 2026) | 1.86 | -- | 1.81799 | 1.9176 | 5 |
FQ1 2026 (Mar 2026) | 1.71 | -- | 1.67138 | 1.76296 | 3 |
FQ4 2025 (Oct 2025) | 1.62286 | 21.13 | 1.6036 | 1.64166 | 4 |
FQ3 2025 (Jul 2025) | 1.63973 | 7.91 | 1.62027 | 1.65873 | 6 |
FQ2 2025 (Jun 2025) | 1.66267 | 17.6 | 1.62511 | 1.71416 | 6 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 2.61B | -- | 2.55B | 2.7B | 4 |
FQ2 2027 (Jun 2027) | 2.6B | -- | 2.54B | 2.69B | 6 |
FQ1 2027 (Mar 2027) | 2.38B | -- | 2.32B | 2.46B | 4 |
FQ4 2026 (Oct 2026) | 2.57B | -- | 2.55B | 2.6B | 4 |
FQ3 2026 (Jul 2026) | 2.61B | -- | 2.58B | 2.63B | 5 |
FQ2 2026 (Jun 2026) | 2.64B | -- | 2.59B | 2.7B | 5 |
FQ1 2026 (Mar 2026) | 2.42B | -- | 2.38B | 2.48B | 6 |
FQ4 2025 (Oct 2025) | 2.44B | 4.88 | 2.41B | 2.46B | 2 |
FQ3 2025 (Jul 2025) | 2.45B | 2.55 | 2.43B | 2.47B | 2 |
FQ2 2025 (Jun 2025) | 2.47B | 4.24 | 2.42B | 2.52B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 1.28 | 1.28 | 100% | |
FQ3 2024 (Sep 2024) | 1.51 | 1.51 | 100% | |
FQ2 2024 (Jun 2024) | 1.37 | 1.37 | 100% | |
FQ1 2024 (Mar 2024) | 1.31 | 1.31 | 100% | |
FQ4 2023 (Dec 2023) | 1.14 | 1.14 | 100% | |
FQ3 2023 (Sep 2023) | 1.29 | 1.29 | 100% | |
FQ2 2023 (Jun 2023) | 1.45 | 1.45 | 100% | |
FQ1 2023 (Mar 2023) | 1.19 | 1.19 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $2.32B | $2317M | 100% |
FQ3 2024 (Sep 2024) | $0B | $2.39B | $2388M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.36B | $2361M | 100% |
FQ1 2024 (Mar 2024) | $0B | $2.19B | $2190M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.21B | $2213M | 100% |
FQ3 2023 (Sep 2023) | $0B | $2.15B | $2151M | 100% |
FQ2 2023 (Jun 2023) | $0B | $2.18B | $2180M | 100% |
FQ1 2023 (Mar 2023) | $0B | $2B | $2000M | 100% |